Patient public involvement and engagement in thrombosis research: not just for the intrepid by Højen, Anette Arbjerg et al.
Res Pract Thromb Haemost. 2021;5:245–246.    |  245wileyonlinelibrary.com/journal/rth2
 
Received: 7 September 2020  |  Accepted: 25 September 2020
DOI: 10.1002/rth2.12451  
L E T T E R  T O  T H E  E D I T O R
Patient public involvement and engagement in thrombosis 
research: Not just for the intrepid
We commend the American Heart Association and the International 
Society on Thrombosis and Haemostasis for their statement on 
venous thromboembolism (VTE) research priorities, developed 
through a survey across 16 scientific organizations and subsequent 
expert panel.1 The authors state, “Collaboration among experts in 
the preclinical and clinical area will provide optimal insight to the 
field and to the patients.”1 Regrettably, one important expert group 
was conspicuous by its absence: the patients. Whereas clinicians 
and scientists have disease-specific expertise, patients have expe-
rience-based expertise, which is important if we want to improve 
the relevance of the research, increase the stakeholders’ trust in the 
research, and increase research adoption.2,3 We could have hoped 
for a new era in thrombosis research where meaningful patient ex-
perience was embedded in the VTE research priorities and not re-
duced to a passing remark on the need to examine patient-centered 
outcomes in a population-based study setup.
We do not imply that VTE researchers are without good con-
science and motivation to improve patient care through advances 
in research; however, evidence suggests that patients can have 
meaningful contributions in all stages of VTE research,3 recognizing 
that during a project, emphasis and input between individuals in a 
research group will fluctuate depending on the expertise required, 
and not all in a research group will be involved in every decision and 
every part of a project.2
Patient engagement in designing, implementing, and disseminat-
ing research has been shown to amplify translation of research into 
clinical practice.3 Thus, while we agree with the authors’ appraisal 
of translational research, we strongly encourage a broader trans-
lational approach throughout the VTE research priorities involving 
patients themselves.
The inclusion of patient representatives in the development 
of VTE clinical guidelines is well established,4 yet the absence of 
patient and public involvement (PPI) in the development of these 
particular VTE research priorities is evident. If we do not engage 
patients as partners when identifying and prioritizing research, 
we risk a disconnect between the research priorities and the true 
needs of patients,2,3,5 a concern shared with at least one of the 
participants in the crowdsourcing survey who, according to the 
Online Appendix, commented, “Did you engage patients in this 
list? Won’t the list just reflect researchers’ current topics?”1 The 
preselected group of topics in the crowdsourcing survey clearly 
reflects physician-centered research priorities and possibly ex-
plains why patient experience is absent in the identified priorities. 
This potentially impedes the understanding and improvement of 
areas such as decision making, compliance, and health-related 
quality of life and the support of grant-funding bodies that have 
strong PPI.
We respectfully continue the call for increased PPI and engage-
ment in shaping VTE research priorities as well as their design, im-
plementation, and dissemination by supporting our campaign to 
Innovate Thrombosis Research Engagement with Patient and Public 
Involvement in Design and Delivery (INTREPID).5 We believe such 
an INTREPID approach would ensure that our research priorities 
align more closely with our patients.
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